July 25, 2024

Bally’s Corporation (BALY): Merger Agreement Triggers Stock Market Rally

The announcement of Bally’s Corporation (NYSE: BALY) entering a merger agreement has significantly influenced its share price on the US stock charts. As of the latest current-market check, BALY stock has risen by 24.41%, reaching $16.82. Bally’s Merger Agreement Bally’s Corporation (BALY) said today that it and Standard General L.P., its biggest common investor, have …

Bally’s Corporation (BALY): Merger Agreement Triggers Stock Market Rally Read More »

Predictive Oncology (POAI) Shares Surge Following Strategic Expansion Announcement

After announcing a strategic expansion, Predictive Oncology Inc. (NASDAQ: POAI) has seen its shares gain significant momentum during the current market session. As of the latest check, POAI stock has surged by 109.35%, trading at $2.24 on the US stock charts. Predictive Oncology Expanding Through AI/ML Driven Drug Discovery Platform With the intention of finding …

Predictive Oncology (POAI) Shares Surge Following Strategic Expansion Announcement Read More »

Molina (MOH) Stock Sees Significant Pre-Market Gains

After unveiling a strategic maneuver and releasing its financial results, Molina Healthcare, Inc. (NYSE: MOH) has seen its shares gain significant momentum on the US stock charts. During the latest pre-market session check, MOH stock experienced a notable surge of 10.74%, reaching $319.74. Strong Fiscal Results in the Second Quarter of 2024 Molina Healthcare’s (MOH) …

Molina (MOH) Stock Sees Significant Pre-Market Gains Read More »

BioCardia (BCDA) Shares Climb In Extended Trading Session

Shares of BioCardia, Inc. (NASDAQ: BCDA) experienced a notable rise during the extended trading session on Wednesday, following recent advancements. As of the latest update, BCDA stock increased by 10.92% on the US stock charts, reaching a price of $3.15. Patent Grant and Technological Advancement The USPTO has awarded Patent No. 12,036,371, entitled “Method of …

BioCardia (BCDA) Shares Climb In Extended Trading Session Read More »

Viking Therapeutics (VKTX) Shares Climb On Robust Quarterly Performance

Following the release of financial results, Viking Therapeutics, Inc. (NASDAQ: VKTX) shares witnessed a significant rise on the US stock charts. As observed in the after-market session on Wednesday, VKTX stock experienced a remarkable increase of 19.62%, reaching $60.30. Financial Performance and Clinical Pipeline Updates Viking Therapeutics (VKTX) revealed its financial results for the first …

Viking Therapeutics (VKTX) Shares Climb On Robust Quarterly Performance Read More »